Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Broman KK Image

      Kristy Kummerow Broman, MD, MPH, FACS

      Department of Surgical Oncology, Division of Surgery

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Surgical Oncology, Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2015Vanderbilt University School of Medicine, Nashville, Tennessee, US, Master of Public Health
      2010Vanderbilt University School of Medicine, Nashville, Tennessee, US, Doctor of Medicine
      2004Rhodes College, Memphis, Tennessee, US, Bachelor of Science

      Postgraduate Training

      2018-2020Clinical Fellow, Complex General Surgical Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
      2013-2016Research Fellow, VA Quality Scholar Program, Tennessee Valley Healthcare System, Nashville, Tennessee
      2010-2018Resident, General Surgery, Vanderbilt University Medical Center, Nashville, Tennessee

      Licenses & Certifications

      2025Texas Medical License
      2021Complex General Surgical Oncology
      2019American Board of Surgery

      Experience & Service

      Administrative Appointments/Responsibilities

      Director, Surgical Health Services Research and Implementation Science, Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2026 - Present

      Co-Lead, Surgical Oncology T32 Program, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2026 - Present

      Honors & Awards

      2025 - PresentInductee, Alpha Omega Alpha Honor Society
      2025 - 2028Pittman Scholar, UAB Heersink School of Medicine
      2024 - PresentVisiting Professorship Award, Association of VA Surgeons
      2023 - 2024Selected for JAMA Surgery, Surgical Outcomes Club
      2022 - PresentInducted Fellow, American College of Surgeons
      2022Selected for Transforming Success, University of Alabama at at Birmingham
      2021 - 2024Top-Performing Provider Selected for Transforming Success Leadership Training Program, University of Alabama at Birmingham
      2020 - PresentBest Reviewer Award - American Journal of Surgery, Association of Women Surgeon

      Selected Presentations & Talks

      National Presentations

      1. 2024. Health System Factors associated with Implementation of Evidence in Surgical Cancer Care. Center for Clinical Quality and Implementation Science. Nashville, Tennessee, US.
      2. 2024. Comparative Health System Performance on Implementation of Evidence in Surgical Cancer Care. Halstead Surgical Society Annual Meeting. Birmingham, Alabama, US.
      3. 2023. Breaking Barriers: Improving Access to Cancer Care through Regionalization. American College of Surgeons Clinical Congress. Boston, Massachusetts, US.
      4. 2022. Primary Breast Sarcoma. Society of Surgical Oncology Annual Cancer Symposium. Houston, Texas, US.
      5. 2022. Finding the Story: Using Qualitative Methods in Clinical Research. American College of Surgeons Clinical Congress. San Diego, California, US.
      6. 2021. Advances in Lymph Node Mapping and Sentinel Lymph Node Biopsy for Melanoma. Society of Nuclear Medicine and Molecular Imaging webinar, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2025 - 2027
      Title:Development of Cancer Care Shortage Areas using Geospatial Analysis and Spatial Network Optimization Techniques
      Funding Source:National Cancer Institute
      Role:Co-I
      ID:R03CA304056
      Date: 2024 - 2025
      Title:Surveillance and Survivorship in Sentinel Lymph Node Positive Melanoma
      Funding Source:Melanoma Research Foundation
      Role:Mentor
      Date: 2023 - Present
      Title:Leveraging Health Systems to Increase Implementation of Evidence-Based Surgical Cancer Care
      Funding Source:National Cancer Institute
      Role:PI
      ID:K08CA283001
      Date: 2022 - 2025
      Title:Impact of Health System Affiliations on Dissemination and Implementation of Evidence-Based Practices in Oncology
      Funding Source:American Society of Clinical Oncology Conquer Cancer
      Role:PI
      Date: 2022 - 2024
      Title:Quality of Care and Patient Preferences for Cancer Surgery at Hub versus Affiliate Sites within Health Systems
      Funding Source:American College of Surgeons
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Montgomery KB, Rademacher N, Richman JS, Bhatia S, Broman KK. Healthcare facility volume and evidence-based practice implementation in surgical care of patients with common cancers. Am J Surg 252:116733, 2026. e-Pub 2026. PMID: 41317677.
      2. Harbaugh C, Broman K. Moving the Needle on Health System Care Delivery: From Observation to Intervention. Ann Surg 283(1):10-12, 2026. e-Pub 2026. PMID: 40899739.
      3. Broman KK, Greenup R, Dossett LA, Ghaferi A. Surgical Health Services Research as a Path to Health System Leadership. Ann Surg 282(6):927-929, 2025. e-Pub 2025. PMID: 40406857.
      4. Wahlen MM, Schroeder MC, Bojorquez PY, Birken SA, Semprini JT, Gorzelitz JS, Seaman AT, Sadri L, Broman K, Lizarraga IM, Charlton ME. A survey of cancer affiliate network hubs in the US: goals, composition, resources, and evaluation. Cancer Causes Control 36(12):1919-1926, 2025. e-Pub 2025. PMID: 40987993.
      5. Rademacher N, Sisk C, Richman JS, Broman K, Wang C. Geospatial Analysis of Commission on Cancer-Accredited Centers Within Cancer Care Utilization-Based Catchment Areas. JCO Clin Cancer Inform 9:e2500163, 2025. e-Pub 2025. PMID: 41435205.
      6. Duncan N, Amu-Nnadi C, Montgomery KB, Rademacher N, Wang C, Richman JS, Bhatia S, Broman KK. An Ecologic Analysis of the Association of Regional Cancer Center Presence with Cancer Mortality for the Continuous United States. Cancer Epidemiol Biomarkers Prev 34(11):1907-1913, 2025. e-Pub 2025. PMID: 40900632.
      7. Baskin AS, Stover MP, Bains M, Montgomery KB, Oslock WM, Broman KK, Dossett LA. Perspectives on Commission on Cancer Standard 5.8 on Lung Cancer: A Qualitative Study. J Surg Res 314:8-17, 2025. e-Pub 2025. PMID: 40714459.
      8. Hollenquest B, Montgomery K, Lucy A, Banks A, Eulo V, Broman K. Effect of a Multidisciplinary Clinic on Time to Treatment for Soft Tissue Sarcoma. J Surg Oncol 132(4):763-772, 2025. e-Pub 2025. PMID: 40788194.
      9. Montgomery KB, Broman KK. ASO Author Reflections: Contemporary Trends in Referral Surgical Cancer Care. Ann Surg Oncol 32(6):3952-3953, 2025. e-Pub 2025. PMID: 40100586.
      10. Montgomery KB, Ross E, Amu-Nnadi C, Bhatia S, Broman KK. Patterns of Referral for Common Cancer Surgery in the United States. Ann Surg Oncol 32(5):3429-3440, 2025. e-Pub 2025. PMID: 39966272.
      11. Broman KK, Herbey I, Hollenquest B, Dykes E, Bhatia S, Ivankova N. Patient preferences for location of cancer surgery in a community cancer affiliate network. Surgery 180:109002, 2025. e-Pub 2025. PMID: 39730266.
      12. Broman KK, Meng Q, Holmqvist A, Balas N, Richman J, Landier W, Hageman L, Ross E, Bosworth A, Te HS, Hollenquest B, Wong FL, Bhatia R, Forman SJ, Armenian SH, Weisdorf DJ, Bhatia S. Incidence of and Risk Factors for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant. JAMA Dermatol 161(3):265-273, 2025. e-Pub 2025. PMID: 39693095.
      13. Montgomery KB, McLeod MC, DePalo DK, Dugan MM, Zager JS, Elleson KM, Sabel MS, Hieken TJ, Kottschade LA, Ollila DW, Pham V, Archer D, Berman RS, Lee AY, Cintolo-Gonzalez JA, McDonald HG, Winchester S, Burke EE, Rhodin KE, Beasley GM, Broman KK. Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional Cohort. Ann Surg Oncol 32(3):1453-1462, 2025. e-Pub 2025. PMID: 39576454.
      14. Montgomery KB, Broman KK. ASO Author Reflections: Investigating Social Risk Factors for Melanoma Nodal Surveillance Adherence in Real-World Populations. Ann Surg Oncol 32(3):1483-1484, 2025. e-Pub 2025. PMID: 39653944.
      15. DePalo DK, Dugan MM, Naqvi SMH, Ollila DW, Hieken TJ, Block MS, van Houdt WJ, Wouters MWJM, Reijers SJM, Asher N, Broman KK, Duncan Z, Anderson M, Gyorki DE, Snow H, Held J, Farma JM, Vetto JT, Hui JYC, Kolbow M, Saw RPM, Lo SN, Long GV, Thompson JF, Kim Y, Karapetyan L, Ny L, van Akkooi ACJ, Olofsson Bagge R, Zager JS. A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases. Cancer 131(1):e35636, 2025. e-Pub 2025. PMID: 39522025.
      16. Jiminez V, Montgomery KB, Hollenquest B, Broman KK. Long-term outcomes of nodal surveillance practices in sentinel node positive melanoma: An early post MSLT-II cohort. Am J Surg 239:116049, 2025. e-Pub 2025. PMID: 39509939.
      17. Montgomery KB, Holder AM, Broman KK. ASO Author Reflections: Synoptic Reporting for Melanoma Nodal Surveillance Ultrasonography. Ann Surg Oncol 31(12):8253-8254, 2024. e-Pub 2024. PMID: 39012465.
      18. Montgomery KB, Duncan ZN, Holder AM, Burgan CM, Galgano SJ, Broman KK. Interdisciplinary Implementation of a Synoptic Reporting Template for Melanoma Nodal Surveillance Ultrasound. Ann Surg Oncol 31(12):8222-8229, 2024. e-Pub 2024. PMID: 38954095.
      19. Balanchivadze N, Blackford AL, Sedhom R, Broman KK, Gupta A, Hussaini SMQ. Geographic Disparities in Head and Neck Cancer Mortality and Place of Death. JAMA Otolaryngol Head Neck Surg 150(8):743-746, 2024. e-Pub 2024. PMID: 38935385.
      20. Amu-Nnadi CN, Ross ES, Garcia NH, Duncan ZN, Correya TA, Montgomery KB, Broman KK. Health System Integration and Cancer Center Access for Rural Hospitals. Am Surg 90(5):1023-1029, 2024. e-Pub 2024. PMID: 38073251.
      21. Montgomery KB, Fazendin JM, Chen H, Broman KK. Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension. Am J Surg 228:173-179, 2024. e-Pub 2024. PMID: 37722937.
      22. Braswell AC, Jiminez V, Montgomery KB, McLeod MC, Broman KK, Eulo V. Racial and ethnic variation in presentation and outcomes of high-grade soft tissue sarcoma at a Southeastern United States comprehensive cancer center. Am J Surg 227:132-136, 2024. e-Pub 2024. PMID: 37865543.
      23. Dykes EM, Montgomery KB, Kennedy GD, Krontiras H, Broman KK. Quality of breast surgery care at a comprehensive cancer center and its rural affiliate hospital. Am J Surg 227:52-56, 2024. e-Pub 2024. PMID: 37805304.
      24. Broman K, Richman J, Ross E, Zengul F, Weech-Maldonado R, Bhatia S. Hub and spoke framework for study of surgical centralization within United States health systems. Am J Surg 226(4):524-530, 2023. e-Pub 2023. PMID: 37156679.
      25. Montgomery KB, Fazendin JM, Broman KK. Evolving variation in the extent of surgery for low-risk papillary thyroid cancer in the United States. Surgery 174(4):828-835, 2023. e-Pub 2023. PMID: 37550165.
      26. Broman KK, Hughes TM, Bredbeck BC, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, O'shea K, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Hotz M, Farma JM, Deneve JL, Fleming MD, Perez M, Baecher K, Lowe M, Bagge RO, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley GM, Hui JYC, Been L, Kruijff S, Sinco B, Sarnaik AA, Sondak VK, Zager JS, Dossett LA. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers. Ann Surg 277(5):e1106-e1115, 2023. e-Pub 2023. PMID: 35129464.
      27. Correya T, Duncan Z, Garcia N, Amu-Nnadi C, Broman K. Incidence and Risk Factors for Incidental Cancer on Melanoma Wide Excisions. J Surg Res 284:24-28, 2023. e-Pub 2023. PMID: 36527767.
      28. Duncan Z, Garcia N, Correya T, Amu-Nnadi C, Broman K. Burden of Care for Patients With In-Transit Melanoma. J Surg Res 283:550-558, 2023. e-Pub 2023. PMID: 36442254.
      29. Mott NM, Duncan ZN, Pesavento CM, Vastardis AF, Bredbeck BC, Harter CA, Dossett LA, Broman KK, Hughes TM. Implementation of melanoma guidelines in the multidisciplinary setting: A qualitative analysis. Am J Surg 225(2):335-340, 2023. e-Pub 2023. PMID: 36180302.
      30. Rattani A, Gaskins J, McKenzie G, Scharf VK, Broman K, Pisu M, Holder A, Dunlap N, Schwartz D, Yusuf MB. Patterns of Care and Data Quality in a National Registry of Black and White Patients with Merkel Cell Carcinoma. Cancers (Basel) 14(20), 2022. e-Pub 2022. PMID: 36291843.
      31. Montgomery KB, Broman KK. ASO Author Reflections: Challenges to Achieving Consistent Nodal Surveillance with Ultrasound in Melanoma. Ann Surg Oncol 29(9):5969-5970, 2022. e-Pub 2022. PMID: 35532829.
      32. Montgomery KB, Correya TA, Broman KK. Real-World Adherence to Nodal Surveillance for Sentinel Lymph Node-Positive Melanoma. Ann Surg Oncol 29(9):5961-5968, 2022. e-Pub 2022. PMID: 35608800.
      33. Eroglu Z, Broman KK, Thompson JF, Nijhuis A, Hieken TJ, Kottschade L, Farma JM, Hotz M, Deneve J, Fleming M, Bartlett EK, Sharma A, Dossett L, Hughes T, Gyorki DE, Downs J, Karakousis G, Song Y, Lee A, Berman RS, van Akkooi A, Stahlie E, Han D, Vetto J, Beasley G, Farrow NE, Hui JYC, Moncrieff M, Nobes J, Baecher K, Perez M, Lowe M, Ollila DW, Collichio FA, Bagge RO, Mattsson J, Kroon HM, Chai H, Teras J, Sun J, Carr MJ, Tandon A, Babacan NA, Kim Y, Naqvi M, Zager J, Khushalani NI. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection. J Immunother Cancer 10(8), 2022. e-Pub 2022. PMID: 36002183.
      34. Broman KK, Richman J, Bhatia S. Evidence and implementation gaps in management of sentinel node-positive melanoma in the United States. Surgery 172(1):226-233, 2022. e-Pub 2022. PMID: 35120732.
      35. Holmberg CJ, Ny L, Hieken TJ, Block MS, Carr MJ, Sondak VK, Ortenwall C, Katsarelias D, Dimitriou F, Menzies AM, Saw RP, Rogiers A, Straker RJ 3rd, Karakousis G, Applewaite R, Pallan L, Han D, Vetto JT, Gyorki DE, Tie EN, Vitale MG, Ascierto PA, Dummer R, Cohen J, Hui JY, Schachter J, Asher N, Helgadottir H, Chai H, Kroon H, Coventry B, Rothermel LD, Sun J, Carlino MS, Duncan Z, Broman K, Weber J, Lee AY, Berman RS, Teras J, Ollila DW, Long GV, Zager JS, van Akkooi A, Olofsson Bagge R. The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study. Eur J Cancer 169:210-222, 2022. e-Pub 2022. PMID: 35644725.
      36. Broman KK, Bettampadi D, Perez-Morales J, Sun J, Kirichenko D, Carr MJ, Eroglu Z, Tarhini AA, Khushalani N, Schabath MB, Sarnaik A, Sondak VK, Zager JS. Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection. Ann Surg Oncol 28(12):6978-6985, 2021. e-Pub 2021. PMID: 34363118.
      37. Broman KK, Hughes T, Dossett L, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma JM, Deneve JL, Fleming MD, Perez MC, Lowe MC, Olofsson Bagge R, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley G, Hui JYC, Been L, Kruijff S, Kim Y, Naqvi SMH, Sarnaik AA, Sondak VK, Zager JS. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). Cancer 127(13):2251-2261, 2021. e-Pub 2021. PMID: 33826754.
      38. Valente SA, Tendulkar RD, Cherian S, Shah C, Ross DL, Lottich SC, Laronga C, Broman KK, Donnelly ED, Bethke KP, Shaw C, Lockney NA, Pederson A, Rudolph R, Hasselle M, Kelemen P, Hermanto U, Ashikari A, Kang S, Hoefer RA, McCready D, Fyles A, Escallon J, Rohatgi N, Graves J, Graves G, Willey SC, Tousimis E, Riley L, Deb N, Tu C, Small W Jr, Grobmyer SR. TARGIT-R (Retrospective): 5-Year Follow-Up Evaluation of Intraoperative Radiation Therapy (IORT) for Breast Cancer Performed in North America. Ann Surg Oncol 28(5):2512-2521, 2021. e-Pub 2021. PMID: 33433786.
      39. Broman KK, Hughes TM, Dossett LA, Sun J, Carr MJ, Kirichenko DA, Sharma A, Bartlett EK, Nijhuis AA, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma J, Deneve JL, Fleming MD, Perez M, Baecher K, Lowe M, Bagge RO, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras RM, Teras J, Farrow NE, Beasley GM, Hui JY, Been L, Kruijff S, Boulware D, Sarnaik AA, Sondak VK, Zager JS. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis. J Am Coll Surg 232(4):424-431, 2021. e-Pub 2021. PMID: 33316427.
      40. Broman KK, Baez H, Mihelic E, Zhu S, Dineen S, Fleming JB, Anaya DA, Pimiento JM. Combined use of advanced practice providers and care pathways reduces the duration of stay after surgery for gastrointestinal malignancies. Surgery 169(4):852-858, 2021. e-Pub 2021. PMID: 32713756.
      41. Hui JYC, Burke E, Broman KK, Marmor S, Jensen E, Tuttle TM, Zager JS. Surgeon decision-making for management of positive sentinel lymph nodes in the post-Multicenter Selective Lymphadenectomy Trial II era: A survey study. J Surg Oncol 123(2):646-653, 2021. e-Pub 2021. PMID: 33289125.
      42. Broman KK, Joya L, Sun W, Zhou JM, Fridley B, Javedan K, Diaz R, Laronga C. Utility of Taking Additional Margins When Performing Breast-Conserving Surgery with Intraoperative Radiation Therapy for Early Breast Cancer. World J Surg 44(10):3410-3416, 2020. e-Pub 2020. PMID: 32696098.
      43. Edwards GC, Broman KK, Martin RL, Smalley WE, Smith L, Snyder RA, Solorzano CC, Dittus RS, Roumie CL. Virtual Colorectal Cancer Surveillance: Bringing Scope Rate to Target. J Am Coll Surg 231(2):257-266, 2020. e-Pub 2020. PMID: 32454089.
      44. Broman KK, Zager JS. An evaluation of talimogene laherparepvec for the treatment of melanoma. Expert Opin Biol Ther 20(1):9-14, 2020. e-Pub 2020. PMID: 31690129.
      45. Broman KK, Parikh AA. ASO Author Reflections: Location of Primary Colorectal Cancer and Risk of Second Primary Malignancy. Ann Surg Oncol 26(Suppl 3):832-833, 2019. e-Pub 2019. PMID: 31732943.
      46. Broman K, Sun W, Zhou JM, Fridley B, Diaz R, Laronga C. Outcomes of selective whole breast irradiation following lumpectomy with intraoperative radiation therapy for hormone receptor positive breast cancer. Am J Surg 218(4):749-754, 2019. e-Pub 2019. PMID: 31345502.
      47. Broman KK, Bailey CE, Parikh AA. Sidedness of Colorectal Cancer Impacts Risk of Second Primary Gastrointestinal Malignancy. Ann Surg Oncol 26(7):2037-2043, 2019. e-Pub 2019. PMID: 30949861.
      48. Kummerow Broman K, Gaskill CE, Faqih A, Feng M, Phillips SE, Lober WB, Pierce RA, Holzman MD, Evans HL, Poulose BK. Evaluation of Wound Photography for Remote Postoperative Assessment of Surgical Site Infections. JAMA Surg 154(2):117-124, 2019. e-Pub 2019. PMID: 30422236.
      49. Feng MP, Baucom RB, Broman KK, Harris DA, Holzman MD, Huang LC, Kaiser JL, Kavalukas SL, Oyefule OO, Phillips SE, Poulose BK, Pierce RA. Early repair of ventral incisional hernia may improve quality of life after surgery for abdominal malignancy: a prospective observational cohort study. Hernia 23(1):81-90, 2019. e-Pub 2019. PMID: 30564978.
      50. Forbes RC, Broman KK, Johnson TB, Rybacki DB, Hannah Gillis AE, Hagemann Williams M, Shaffer D, Feurer ID, Hale DA. Implementation of telehealth is associated with improved timeliness to kidney transplant waitlist evaluation. J Telemed Telecare 24(7):485-491, 2018. e-Pub 2018. PMID: 28649902.
      51. Kummerow Broman K, Phillips SE, Faqih A, Kaiser J, Pierce RA, Poulose BK, Richards WO, Sharp KW, Holzman MD. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: long-term symptomatic follow-up of a prospective randomized controlled trial. Surg Endosc 32(4):1668-1674, 2018. e-Pub 2018. PMID: 29046957.
      52. Kummerow Broman K, Ward MJ, Poulose BK, Schwarze ML. Surgical Transfer Decision Making: How Regional Resources are Allocated in a Regional Transfer Network. Jt Comm J Qual Patient Saf 44(1):33-42, 2018. e-Pub 2018. PMID: 29290244.
      53. Faqih A, Broman KK, Huang LC, Phillips SE, Holzman MD, Pierce RA, Poulose BK, Yachimski PS. Frequency of endoscopic surveillance for Barrett's esophagus is influenced by health insurance status: results from a population-based analysis. Dis Esophagus 30(11):1-8, 2017. e-Pub 2017. PMID: 28881902.
      54. Broman KK, Phillips SE, Ehrenfeld JM, Patel MB, Guillamondegui OM, Sharp KW, Pierce RA, Poulose BK, Holzman MD. Identifying Futile Interfacility Surgical Transfers. Am Surg 83(8):866-870, 2017. e-Pub 2017. PMID: 28822393.
      55. Kelly Wu W, Broman KK, Brownie ER, Kauffmann RM. Ipilimumab-induced Guillain-Barre Syndrome Presenting as Dysautonomia: An Unusual Presentation of a Rare Complication of Immunotherapy. J Immunother 40(5):196-199, 2017. e-Pub 2017. PMID: 28452849.
      56. Kummerow Broman K, Kensinger C, Hart H, Mathisen J, Kripalani S. Closing the loop: a process evaluation of inpatient care team communication. BMJ Qual Saf 26(1):30-32, 2017. e-Pub 2017. PMID: 26614773.
      57. Kummerow Broman K, Huang LC, Faqih A, Phillips SE, Baucom RB, Pierce RA, Holzman MD, Sharp KW, Poulose BK. Hidden Morbidity of Ventral Hernia Repair with Mesh: As Concerning as Common Bile Duct Injury?. J Am Coll Surg 224(1):35-42, 2017. e-Pub 2017. PMID: 27725219.
      58. Kummerow Broman K, Hayes RM, Kripalani S, Vasilevskis EE, Phillips SE, Ehrenfeld JM, Holzman MD, Sharp KW, Pierce RA, Nealon WH, Poulose BK. Interhospital transfer for acute surgical care: does delay matter?. Am J Surg 212(5):823-830, 2016. e-Pub 2016. PMID: 27381817.
      59. Kummerow Broman K, Roumie CL, Stewart MK, Castellanos JA, Tarpley JL, Dittus RS, Pierce RA. Implementation of a Telephone Postoperative Clinic in an Integrated Health System. J Am Coll Surg 223(4):644-51, 2016. e-Pub 2016. PMID: 27545100.
      60. Broman KK, Poulose BK, Phillips SE, Ehrenfeld JM, Sharp KW, Pierce RA, Holzman MD. Unnecessary Transfers for Acute Surgical Care: Who and Why?. Am Surg 82(8):672-8, 2016. e-Pub 2016. PMID: 27657580.
      61. Kummerow Broman K, Vella MA, Tarpley JL, Dittus RS, Roumie CL. Identification of postoperative care amenable to telehealth. Surgery 160(2):264-71, 2016. e-Pub 2016. PMID: 27059636.
      62. Kummerow Broman K, Kensinger C, Phillips C, Fesseha B, Fill MM, Borges N, Mathisen J, Allen D, Land E, Patel N. Characterizing the Clamor: An In-Depth Analysis of Inpatient Paging Communication. Acad Med 91(7):1015-21, 2016. e-Pub 2016. PMID: 26910895.
      63. Baucom RB, Feurer ID, Shelton JS, Kummerow K, Holzman MD, Poulose BK. Surgeons, ERCP, and laparoscopic common bile duct exploration: do we need a standard approach for common bile duct stones?. Surg Endosc 30(2):414-423, 2016. e-Pub 2016. PMID: 26092008.
      64. Kummerow Broman K, Phillips S, Hayes RM, Ehrenfeld JM, Holzman MD, Sharp K, Kripalani S, Poulose BK. Insurance status influences emergent designation in surgical transfers. J Surg Res 200(2):579-85, 2016. e-Pub 2016. PMID: 26346526.
      65. Kummerow Broman K, Oyefule OO, Phillips SE, Baucom RB, Holzman MD, Sharp KW, Pierce RA, Nealon WH, Poulose BK. Postoperative Care Using a Secure Online Patient Portal: Changing the (Inter)Face of General Surgery. J Am Coll Surg 221(6):1057-66, 2015. e-Pub 2015. PMID: 26453260.
      66. Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg 150(1):9-16, 2015. e-Pub 2015. PMID: 25408966.
      67. Shelton J, Kummerow K, Phillips S, Arbogast PG, Griffin M, Holzman MD, Nealon W, Poulose BK. Patient safety in the era of the 80-hour workweek. J Surg Educ 71(4):551-9, 2014. e-Pub 2014. PMID: 24776874.
      68. Kummerow KL, Shelton J, Phillips S, Holzman MD, Nealon W, Beck W, Sharp K, Poulose BK. Predicting complicated choledocholithiasis. J Surg Res 177(1):70-4, 2012. e-Pub 2012. PMID: 22682715.
      69. Shelton J, Kummerow K, Phillips S, Griffin M, Holzman MD, Nealon W, Pinson CW, Poulose BK. An urban-rural blight? Choledocholithiasis presentation and treatment. J Surg Res 173(2):193-7, 2012. e-Pub 2012. PMID: 21737099.
      70. Poulose BK, Phillips S, Nealon W, Shelton J, Kummerow K, Penson D, Holzman MD. Choledocholithiasis management in rural America: health disparity or health opportunity?. J Surg Res 170(2):214-9, 2011. e-Pub 2011. PMID: 21571311.
      71. Poulose BK, Kummerow KL, Nealon WH, Shelton JS, Masys DR, Holzman MD. Biliary obstruction during cholecystectomy: endoscopic retrograde cholangiopancreatography, evade, or explore?. Am Surg 77(8):985-91, 2011. e-Pub 2011. PMID: 21944511.

      Review Articles

      1. Broman KK, Joyce D, Binitie O, Letson GD, Gonzalez RJ, Choi J, Mullinax JE. Intraoperative Localization Using an Implanted Radar Reflector Facilitates Resection of Non-Palpable Trunk and Extremity Sarcoma. Ann Surg Oncol 28(6):3366-3374, 2021. e-Pub 2021. PMID: 33073344.
      2. Broman KK, Zager JS. Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma. Melanoma Manag 6(3):MMT26, 2019. e-Pub 2019. PMID: 31807277.
      3. Broman KK, Dossett LA, Sun J, Eroglu Z, Zager JS. Update on BRAF and MEK inhibition for treatment of melanoma in metastatic, unresectable, and adjuvant settings. Expert Opin Drug Saf 18(5):381-392, 2019. e-Pub 2019. PMID: 30977681.

      Other Articles

      1. Perez-Morales J, Broman KK, Bettampadi D, Haver MK, Zager JS, Schabath MB Recurrence Patterns for Regionally Metastatic Melanoma Treated in the Era of Adjuvant Therapy: A Systematic Review and Meta-Analysis. Ann Surg Oncol 30(4):2364-2374, 2023. PMID: 36479663.
      2. . PMID: 23008855.

      Editorials

      1. Broman K, Goldstein LE, Johnson HM, Cannada LK, Tan SA. Supporting the bereaved surgeon. Am J Surg 243:116137, 2025. PMID: 39668058.

      Books (edited and written)

      1. Kristy Kummerow Broman, MD, MPH, FACS, Montgomery KB. Head and Neck Melanoma. Clinical Scenarios in Surgery: Decision Making and Operative Technique. Wolters Kluwer, 2023.
      2. Kristy Kummerow Broman, MD, MPH, FACS, Poulose B. Endoscopic Retrograde Cholangiopancreatography. The SAGES Manual: Operating through the Endoscope. Springer, 2016.

      Letters to the Editor

      1. Jiminez V, Garcia N, Montgomery KB, Huang C, Bergman D, Pavlidakey P, Francisco L, Broman KK. Diagnosis and Management of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma in a Large Institutional Cohort. J Cutan Med Surg 29: 421-423, 2025.
      2. Montgomery KB, Holder AM, Burgan CM, Galgano SJ, Broman KK. Is it Time for Synoptic Reporting in Melanoma Nodal Surveillance Ultrasonography?. Ann Surg Oncol 30: 5327-5328, 2023.
      3. Broman KK, Poulose B, Evans H, Fernandes-Taylor S. Apps incorporating clinical photography offer the potential to improve care. Bull Am Coll Surg 101: 44, 2016.
      4. Vella MA, Kummerow Broman K, Tarpley JL, Dittus RS, Roumie CL. Postoperative Telehealth Visits: Assessment of Quality and Preferences of Veterans. JAMA Surg 150: 1197-9, 2015.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 19, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Broman Laboratory

      • Surgical Oncology department

      • Health Services Research department

      • Surgery division

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top